A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
Clinical trial NCT07582315 · RECRUITING
Trial details
- NCT number
- NCT07582315
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2028-12-01
- Enrollment
- 538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.